三级中心神经皮肤黑变病患者的临床随访:诊断标准的修改建议
伊朗一家儿童转诊医院2012—2019年连续管理8例神经皮肤黑变病(NCM)患者,诊断时均行脑MRI与皮肤活检。中位随访25.75±13.81个月,死亡率37.5%,作者据此提出诊断标准修改与随访监测建议。
要点
- NCM罕见且无特异管理指南,需个体化随访监测。
- 本组Dandy-Walker综合征占50%、分流依赖性脑积水占37.5%。
- 作者提出诊断标准修改及随访监测推荐。
核心结论
- NCM因罕见缺乏特异管理指南,本研究提出诊断标准修改及随访监测建议。
研究设计与样本
- 回顾性描述性研究,2012—2019年伊朗一家儿童转诊医院连续管理8例NCM患者,诊断时均行脑MRI和皮肤活检。
主要发现
- 平均随访25.75±13.81个月,75%患者为男性。
- MRI表现多为颞叶(75%)、小脑(62.5%)、脑干(50%)和丘脑(12.5%)高信号病灶。
- Dandy-Walker综合征4例(50%),分流依赖性脑积水3例(37.5%)。
- 皮肤恶性黑色素瘤2例(25%),中枢神经系统恶性受累3例(37.5%)。
- 死亡率为37.5%。
关键数值与推荐
- 原文提出对诊断标准进行修改,并提出随访监测建议,但未给出具体条款与数值。
临床怎么用
- 对NCM患者应结合脑MRI与皮肤活检诊断,并按所提建议进行随访监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Neurocutaneous melanosis (NCM) is a rare congenital syndrome. Except for some retrospective studies, information on clinical follow-up and management of these patients are limited. This study aimed to review our experience on diagnostic protocol and clinical follow-up of patients with NCM in a referral children's hospital in Iran. METHODS: Between 2012 and 2019, eight patients with NCM were consecutively managed in our center. Brain magnetic resonance imaging and cutaneous biopsy were done in all patients at diagnosis. Follow-up surveillance and characteristics of the disease are described. RESULTS: The mean follow-up period was 25.75 ± 13.81 months, and 75% of patients were male. Most magnetic resonance imaging findings were hypersignal lesions in the temporal lobe (75%), cerebellum (62.5%), brainstem (50%), and thalamus (12.5%). Dandy-Walker syndrome was found in 4 patients (50%), and shunt-dependent hydrocephalus was found in 3 patients (37.5%). Cutaneous malignant melanoma and malignant involvement of the central nervous system were found in 2 (25%) and 3 cases (37.5%), respectively. The mortality rate was 37.5%. CONCLUSIONS: There are no specific guidelines for management of NCM due to the rarity of the disease. This study proposed modifications in diagnostic criteria, as well as recommendations for follow-up surveillance.
引用
- Habibi Z, Ebrahimi H, Meybodi KT, et al. Clinical Follow-Up of Patients with Neurocutaneous Melanosis in a Tertiary Center; Proposed Modification in Diagnostic Criteria. World Neurosurg. 2020. PMID: 33246180. doi:10.1016/j.wneu.2020.11.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。